Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer

Condition:   Anaplastic Thyroid Cancer
Intervention:   Drug: Pembrolizumab
Sponsors:   University of Texas Southwestern Medical Center;   Merck Sharp & Dohme Corp.
Not yet recruiting - verified February 2016

from #ORL via xlomafota13 on Inoreader http://ift.tt/1KHjGDv
via IFTTT